Ian Ingram from MedPage Today - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting		Bronchoscopes Recalled Over Burns, Fires in Patients' Airways - 5 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 5 months ago FDA OKs Maintenance Option for High-Risk Neuroblastoma - 5 months ago Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial - 5 months ago Pomalidomide Cuts Severe Epistaxis in Genetic Bleeding Disorder - 5 months ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - 5 months ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - 5 months ago Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients - 5 months ago Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials - 5 months ago Completely Oral Regimen Effective, Feasible in APL - 5 months ago Non-Covalent BTK Inhibitor Approved for CLL - 5 months ago Two Approaches for Infected Necrotizing Pancreatitis Go Head-to-Head - 6 months ago Higher-Dose Fluvoxamine Fails for COVID Outpatients - 6 months ago First At-Home Test for Chlamydia and Gonorrhea Authorized by FDA - 6 months ago Lymphoma Drug Copanlisib to Be Pulled From U.S. Market - 6 months ago First Chikungunya Vaccine Lands Conditional FDA Approval - 6 months ago New Oral Drug Approved for Metastatic Colorectal Cancer - 6 months ago New Options Challenge Standard Treatments in EGFR-Mutant NSCLC - 7 months ago Randomized Trial Backs HIF-2a Inhibition in Advanced RCC - 7 months ago Tebentafusp's OS Benefit in Uveal Melanoma Holds Up at 3 Years - 7 months ago